Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.

Latent Epstein-Barr virus (EBV) infection and growth transformation of B lymphocytes is characterized by EBV nuclear and membrane protein expression (EBV nuclear antigen [EBNA] and latent membrane protein [LMP], respectively). LMP1 is known to be an oncogene in rodent fibroblasts and to induce B-lym...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Yayımlandı:	J Virol
Asıl Yazarlar:	Wang, F, Gregory, C, Sample, C, Rowe, M, Liebowitz, D, Murray, R, Rickinson, A, Kieff, E
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 1990
Konular:	Research Article
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC249392/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2157887/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.64.5.2309-2318.1990
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.

Benzer Materyaller